This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full‐thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine. Issue 2 (26th August 2022)
Record Type:
Journal Article
Title:
A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full‐thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine. Issue 2 (26th August 2022)
Main Title:
A case of refractory hypertrophic lupus erythematosus on the face whose irreversible skin fibrosis was treated by local full‐thickness skin graft under disease control with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine
Abstract : Hypertrophic lupus erythematosus (HLE) remains pose a treatment challenge, and often displays disfiguring scar with cosmetic and/or functional impairment. We report a male case of refractory hypertrophic lupus erythematosus on the face, whose disease activity was controlled with a combined use of topical and systemic immunosuppressants, and hydroxychloroquine. The persisted, irreversible fibrotic skin mass was finally treated with surgical approach using full‐thickness skin graft, achieving a favorable cosmetic result.